Invention Grant
- Patent Title: Oligonucleotide constructs and uses thereof
-
Application No.: US16179786Application Date: 2018-11-02
-
Publication No.: US10905767B2Publication Date: 2021-02-02
- Inventor: Sergei Gryaznov , Leonid Beigelman , Theodore Yun
- Applicant: Janssen BioPharma, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Janssen BioPharma, Inc.
- Current Assignee: Janssen BioPharma, Inc.
- Current Assignee Address: US CA South San Francisco
- Main IPC: A61K47/54
- IPC: A61K47/54 ; A61P31/20 ; A61P35/00 ; A61K39/39 ; A61K47/22 ; A61K47/26 ; C12Q1/6876 ; A61K47/14 ; A61K9/00 ; A61K31/7088 ; A61K39/00
Abstract:
Oligodeoxynucleotide-based immunostimulatory Toll-Like Receptor 9 (TLR9) agonists are described. Also described are compositions comprising the TLR9 agonists, methods of making the TLR9 agonists, and methods of using the TLR9 agonists to treat immune diseases, disorders or conditions, such as viral infections or cancer.
Public/Granted literature
- US20190160173A1 OLIGONUCLEOTIDE CONSTRUCTS AND USES THEREOF Public/Granted day:2019-05-30
Information query
